Clinical trial
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the…
NCT00002090 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00002090 |
|---|---|
| Title | An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) |
| Official title | An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-Intracellulare Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | Azithromycin |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: